BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Business
Front Page 
UK Politics 
Market Data 
Your Money 
Business Basics 
Talking Point 
In Depth 

THe BBC's Mark Gregory
Glaxo has come under pressure to lower prices
 real 28k

The BBC's Samantha Simmonds
"Many people simply go untreated"
 real 56k

Wednesday, 21 February, 2001, 21:10 GMT
Glaxo offers cheaper Aids drugs
African aids sufferer
Many Aids sufferers can't afford Glaxo's drugs
The world's biggest pharmaceuticals company, GlaxoSmithKline, has promised to supply charities with discounted drugs to help tackle the high price of Aids treatments.

The offer came as the company, recently created from the merger of Glaxo Wellcome and SmithKline Beecham, reported a 13% rise in its pre-tax profits for last year, to 5.327bn ($7.689m).

The pharmaceutical industry should drop their prices before we get to a level of political crisis

Dr Sam Ongeri, Kenyan Minister for Public Health

It said strong world-wide demand for drugs to treat Aids, asthma and depression had contributed to the increase.

The charity Oxfam welcomed the move, but said it did not address the central problem, which was the systematic use of patent rules to keep low-cost drugs out of poor countries.

GlaxoSmithKline has been at the centre of criticism that its profits come, in part, from overcharging for anti-Aids drugs in developing countries.


The criticism has been spearheaded by charities such as Oxfam and Medecins Sans Frontieres.

They say Glaxo - and other drugs companies - have been grossly overcharging for Aids treatments while, at the same time, preventing poor countries making cheaper copies of their patented medicines.

AIDS drugs
Drugs companies urged to lower prices
Among the examples quoted was a treatment available in India costing less than $500. Oxfam said Glaxo sold the same cure in other countries for $10,000.

In Kenya, a coalition of aid organisations has declared its intention to go ahead and order such drugs from manufacturers which copy patented drugs.

Samantha Bolton, a Nairobi-based spokeswoman for Medecins Sans Frontieres, told the BBC there was no other way out as the cost of $600 a year was unaffordable in a country where the average annual income was only $270.

The Kenyan Minister for Public Health, Dr Sam Ongeri, said his government would introduce a bill in parliament next month to allow compulsory licensing, which would enable aid agencies to import generic drugs.

Mr Ongeri said he expected drugs companies to protest, but warned them to act before the situation deteriorated into a political crisis.

Glaxo's promise

In a move to head off the criticism, GlaxoSmithKLine's chief executive Jean-Pierre Garnier said his company would offer heavy discounts on Aids drugs.

They would be made available to non-profit organisations working in developing countries.

What we want is for the international community to encourage governments to take advantage of generic cheaper medicines

Samantha Bolton, Medecins Sans Frontieres
The offer - of a 90% reduction - is similar to a package offered by the Bombay-based Cipla Ltd, which announced early in February that it would be supplying the triple-cocktail treatment to Medecins Sans Frontieres.

Drug companies have, in the past, threatened to sue Cipla for exporting patented drugs.

Under WTO rules, governments are allowed to issue compulsory licenses that allow generic drugs to be manufactured, or allow "parallel importation" of cheaper drugs.

But drug companies are challenging this in a lawsuit against the South African government. They allege that it violated international law by allowing the import and manufacture of generic equivalents of patented drugs.

However, in parallel to that, and in an effort to stave off criticism, the companies have recently been negotiating deals with individual governments to lower prices.

Search BBC News Online

Advanced search options
Launch console
See also:

03 Feb 01 | Americas
Brazil in US Aids drugs row
02 Jul 99 | Aids
What is Aids?
24 Oct 00 | Aids
Aids drugs factfile
12 May 00 | Africa
Aids initiative 'no magic cure'
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Business stories are at the foot of the page.

E-mail this story to a friend

Links to more Business stories